In summary, our findings suggest a distinct set of biomarkers associated with response to ICB in a hypermutated syngeneic glioma model that is dominated by innate (absence of intratumoral macrophages and absence of PD-L1 on intratumoral macrophages) rather than adaptive immune parameters (Fig. 5f). The gene discussed is CD274; the disease is glioma.